Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide Augmentation of Varenicline for Smoking Cessation
NCT01685996Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Sep 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing Zonisamide + Varenicline with Placebo + Varenicline (2 arms). Primary endpoint: Percent Participants Abstinent From Smoking During Study Weeks 7-10. Started Sep 2012; status: completed.
02
Drugs
zonisamide
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01685996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01685996.